The GLP is committed to full transparency. Download and review our 2019 Annual Report

CBD fraud? Fate of controversial CBD industry could be decided by lawsuits alleging misleading marketing

| | January 13, 2020

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Since the Food and Drug Administration can’t figure out whether supplements that contain cannabidiol, the marijuana-adjacent oil known as CBD, are legal, can a customer who thought they were buying a legal product demand their money back?

A group of remorseful CBD users is suing to test that theory, and it’s going after the companies that put CBD on the map.

In two major lawsuits recently filed against Charlotte’s Web and CV Sciences, two of the largest CBD manufacturers in the country, consumers allege that the companies engaged in “false, fraudulent, unfair, deceptive, and misleading” marketing of their CBD products by claiming they were run-of-the-mill dietary supplements, like vitamin D or iron.

Related article:  Were ‘crucial contributors’ snubbed in awarding Nobel prize for cancer immunotherapy?

In all of the cases, they are asking a judge to force the companies to return all of the profits they’ve made from those sales, which could decimate the nascent industry.

“The implications are huge,” said Daniel Fabricant, the CEO of the Natural Products Association. If the companies lose the lawsuits, he said, “I’m not going to say [the CBD industry] goes away, but I think it gets pretty close to going away.”

Read full, original post: A spate of new class-action lawsuits threaten the CBD industry. Will they force Washington to act?

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend